Role of 5-lipoxygenase in the multiple organ failure induced by zymosan
- PMID: 15241586
- DOI: 10.1007/s00134-004-2353-y
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan
Abstract
Objective: This study investigated the role of 5-lipoxygenase in the pathogenesis of multiple organ failure (MOF) induced by zymosan.
Design: Male mice with a targeted disruption of the 5-lipoxygenase gene (5-LOKO) and littermate wild-type (WT) controls (5-LOWT) were used to evaluate the role of 5-lipoxygenase (5-LO) in the pathogenesis of MOF.
Setting: University research laboratory.
Interventions and measurements: MOF was induced by peritoneal injection of zymosan (500 mg/kg i.p. as a suspension in saline) in 5-LOWT and in 5-LOKO mice. MOF was assessed 18 h after administration of zymosan and monitored for 12 days (for loss of body weight and mortality).
Results: A severe inflammatory process induced by zymosan administration in WT mice coincided with the damage of lung and small intestine, as assessed by histological examination. Myeloperoxidase activity indicative of neutrophil infiltration and lipid peroxidation were significantly increased in zymosan-treated WT mice. Zymosan in the WT mice also induced a significant increase in the plasma level of nitrite/nitrate. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to ICAM-1 and P-selectin in the lung and intestine of zymosan-treated WT mice. In contrast, the degree of (a) peritoneal inflammation and tissue injury, (b) upregulation/expression of P-selectin and ICAM-1, and (c) neutrophil infiltration were markedly reduced in intestine and lung tissue obtained from zymosan-treated 5-LO deficient mice. Zymosan-treated 5-LOKO showed also a significantly decreased mortality.
Conclusions: These findings clearly demonstrate that 5-LO exerts a role in zymosan-induced nonseptic shock.
Similar articles
-
Role of interleukin-6 in a non-septic shock model induced by zymosan.Eur Cytokine Netw. 1999 Jun;10(2):191-203. Eur Cytokine Netw. 1999. PMID: 10400825
-
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.Shock. 2001 Jul;16(1):51-8. doi: 10.1097/00024382-200116010-00010. Shock. 2001. PMID: 11442316
-
Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.Shock. 2006 Nov;26(5):477-84. doi: 10.1097/01.shk.0000230299.78515.2c. Shock. 2006. PMID: 17047518
-
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.Crit Care Med. 1999 Aug;27(8):1524-32. doi: 10.1097/00003246-199908000-00021. Crit Care Med. 1999. PMID: 10470760
-
Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome.Shock. 2005 Apr;23(4):291-7. doi: 10.1097/01.shk.0000155350.95435.28. Shock. 2005. PMID: 15803050 Review.
Cited by
-
The 5-lipoxygenase pathway is required for acute lung injury following hemorrhagic shock.Shock. 2012 Jun;37(6):599-604. doi: 10.1097/SHK.0b013e31824ee7bc. Shock. 2012. PMID: 22392149 Free PMC article.
-
Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.J Inflamm (Lond). 2010 Feb 18;7:12. doi: 10.1186/1476-9255-7-12. J Inflamm (Lond). 2010. PMID: 20167109 Free PMC article.
-
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells.Biologics. 2008 Mar;2(1):151-60. doi: 10.2147/btt.s2542. Biologics. 2008. PMID: 19707438 Free PMC article.
-
Effects of β-glucan pretreatment on acetylsalicylic acid-induced gastric damage: An experimental study in rats.Curr Ther Res Clin Exp. 2010 Dec;71(6):369-83. doi: 10.1016/S0011-393X(10)80003-7. Curr Ther Res Clin Exp. 2010. PMID: 24688156 Free PMC article.
-
Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, experimental studies.Intensive Care Med. 2005 Mar;31(3):356-72. doi: 10.1007/s00134-005-2573-9. Epub 2005 Feb 18. Intensive Care Med. 2005. PMID: 15719149 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous